Cu(II) Propionyl-Thiazole Thiosemicarbazone Complexes: Crystal Structure, Inhibition of Human Topoisomerase IIα, and Activity against Breast Cancer Cells
Open Access
- 1 January 2018
- journal article
- research article
- Published by Scientific Research Publishing, Inc. in Open Journal of Medicinal Chemistry
- Vol. 08 (02), 30-46
- https://doi.org/10.4236/ojmc.2018.82004
Abstract
Two new thiosemicarbazone ligands, 2-propionylthiazole ethylthiosemicarbazone (PTZ-ETSC), and 2-propionylthiazole tert-butylthiosemicarbazone (PTZ-tBTSC), along with their two copper(II) complexes, [Cu(PTZ-ETSC)Cl] and [Cu(PTZ-tBTSC)Cl], are reported here for the first time. Once characterized by NMR and MS, these mono-anionic tridentate ligands were reacted with Cu2+ to form the square planar metal complexes [Cu(PTZ-ETSC)Cl] and [Cu(PTZ-tBTSC)Cl]. The x-ray crystal structure of the [Cu(PTZ-tBTSC)Cl] complex shows that the complex adopts a square planar arrangement around the copper(II) ion, but forms a sulfur-bridged dimer in the solid state. Both of the copper complexes displayed strong inhibition of human topoisomerase IIα at activities between 2-4 μM for [Cu(PTZ-ETSC)Cl], and between 8-10 μM for the [Cu(PTZ-tBTSC)Cl] complex. The EC50 values for the MDA-MB-231 breast cancer cell line were 82.6 μM for (PTZ-ETSC), 17.9 μM for [Cu(PTZ- ETSC)Cl], 97.8 μM for (PTZ-tBTSC), and 1.41 μM for [Cu(PTZ-tBTSC)Cl]. The EC50 values for the MCF7 breast cancer cell lines were 9.36 μM for (PTZ-ETSC), 0.13 μM for [Cu(PTZ-ETSC)Cl], 0.333 μM for (PTZ-tBTSC), and 0.093 μM for [Cu(PTZ-tBTSC)Cl].Keywords
This publication has 32 references indexed in Scilit:
- Study of copper(II) complexes of two diacetyl monooxime thiosemicarbazones: X-ray crystal structure and magneto-structural correlation of [Cu(dmoTSCH)Cl]2·H2O (dmoTSCH=monoanion of diacetyl monooxime thiosemicarbazone)Polyhedron, 2012
- Novel Thiosemicarbazones of the ApT and DpT Series and Their Copper Complexes: Identification of Pronounced Redox Activity and Characterization of Their Antitumor ActivityJournal of Medicinal Chemistry, 2010
- Thiosemicarbazones from the Old to New: Iron Chelators That Are More Than Just Ribonucleotide Reductase InhibitorsJournal of Medicinal Chemistry, 2009
- A short history of SHELXActa Crystallographica Section A Foundations of Crystallography, 2007
- Future of ToxicologyIron Chelators and Differing Modes of Action and Toxicity: The Changing Face of Iron Chelation TherapyChemical Research in Toxicology, 2007
- A Ferrous-triapine complex mediates formation of reactive oxygen species that inactivate human ribonucleotide reductaseMolecular Cancer Therapeutics, 2006
- Structural and spectral studies on four coordinate copper(II) complexes of 2-benzoylpyridine N(4),N(4)-(butane-1,4-diyl)thiosemicarbazonePolyhedron, 2003
- Copper(II) complexes of 2-benzoylpyridine 4N-substituted thiosemicarbazonesPolyhedron, 1995
- To-day's Drugs: MethisazoneBMJ, 1964
- THE TUBERCULOSTATIC ACTIVITY OF SOME THIOSEMICARBAZONESJournal of Pharmacy and Pharmacology, 1951